Bluejay Diagnostics, Inc. (BJDX)

Bluejay Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.3	2.21	10.11	19.05	0.91
Cash & Short-Term Investments	4.3	2.21	10.11	19.05	0.91
Cash Growth	94.79%	-78.17%	-46.90%	1987.75%	850.27%
Inventory	-	-	-	-	0.08
Prepaid Expenses	0.6	0.75	1.67	1.61	0.06
Other Current Assets	-	0.27	-	-	-
Total Current Assets	4.9	3.22	11.79	20.66	1.06
Property, Plant & Equipment	1.72	1.62	1.7	0.34	0.46
Other Long-Term Assets	0.04	0.03	0.04	0.02	-
Total Assets	6.66	4.87	13.52	21.02	1.52
Accounts Payable	0.15	0.49	0.64	0.3	0.37
Accrued Expenses	0.55	1.11	0.83	0.34	0.13
Short-Term Debt	-	-	-	-	0.01
Current Portion of Long-Term Debt	-	-	-	-	1.04
Current Portion of Leases	0.12	0.17	0.17	-	-
Other Current Liabilities	-	-	-	-	0.28
Total Current Liabilities	0.81	1.77	1.64	0.64	1.85
Long-Term Leases	0.12	0.2	0.34	-	-
Total Liabilities	0.93	1.97	1.98	0.64	1.85
Common Stock	0	-	0	0	0
Additional Paid-In Capital	40.4	29.85	28.54	28.07	-
Retained Earnings	-34.67	-26.95	-17	-7.69	-4.21
Total Common Equity	5.73	2.89	11.54	20.38	-4.21
Shareholders' Equity	5.73	2.89	11.54	20.38	-0.33
Total Liabilities & Equity	6.66	4.87	13.52	21.02	1.52
Total Debt	0.24	0.37	0.51	-	1.06
Net Cash (Debt)	4.07	1.84	9.6	19.05	-0.14
Net Cash Growth	121.19%	-80.85%	-49.59%	-	-
Net Cash Per Share	22.17	-	-	-	-
Filing Date Shares Outstanding	0.55	-	-	-	-
Total Common Shares Outstanding	0.55	-	-	-	-
Working Capital	4.09	1.45	10.15	20.02	-0.79
Book Value Per Share	10.34	-	-	-	-
Tangible Book Value	5.73	2.89	11.54	20.38	-4.21
Tangible Book Value Per Share	10.34	-	-	-	-
Machinery	0.31	1.43	1.41	0.77	0.76
Construction In Progress	1.35	1.05	0.38	0.02	-
Leasehold Improvements	0.04	0.04	0.04	-	-

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q